An emollient PLUS balm is useful for the management of xerosis in cancer-treated patients: a real-world, prospective, observational, multicenter study

This emollient was effective at reducing the severity of xerosis and other clinical symptoms, and at lessening the impact of skin manifestations on patient quality of life, regardless of the anticancer therapy received by the patient.
The product can be useful in the supportive care of cancer-treated patients who develop xerosis, regardless of the anticancer treatment they have received

 

Voir l'infographie